ArticleApplied microbiology and biotechnology2026
Chb and nag genes drive N,N'-diacetylchitobiose metabolism in probiotic Lacticaseibacillus paracasei.
Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The persistence of commensal bacteria and administered probiotics in the human gut depends to some extent on their capacity to metabolize diet and host-derived glycans. N,N'-Diacetylchitobiose (N-acetylglucosamine-β-1,4-N-acetylglucosamine; ChbNAc) is a component of N-glycosylated proteins and also the major degradation product of chitin. We have identified in Lacticaseibacillus paracasei BL23 a gene cluster, named chb, involved in the catabolism of ChbNAc. The cluster encodes a transcriptional regulator (ChbR), a cellobiose-type phosphoenolpyruvate-dependent sugar phosphotransferase system (PTS) IIC (ChbC), IIA (ChbA) and IIB (ChbB) components, a DUF3284-containing protein (ChbD), and a glycoside hydrolase of the newly identified GH170 family (ChbE). Inactivation of chbC or chbE prevents the growth of L. paracasei in ChbNAc, suggesting that the PTS is involved in its transport and phosphorylation, and that the putative hydrolase ChbE may be acting on the resulting phosphorylated ChbNAc. An L. paracasei mutant with inactivated nagA, encoding an N-acetylglucosamine-6P deacetylase, was also defective in ChbNAc utilization, indicating that the transformation of N-acetylglucosamine-6P into glucosamine-6P by NagA is necessary for ChbNAc metabolism. Transcriptional analysis showed that the chb genes and the nagA gene are regulated by substrate-specific induction mediated by the transcriptional repressors ChbR and NagR, respectively. In addition, both transcriptional regulators repressed the nagB gene, which encodes a glucosamine-6P deaminase that catalyzes the conversion of glucosamine-6P into the glycolytic intermediate fructose-6P. We characterized for the first time the genes responsible for ChbNAc metabolism in a member of the Lactobacillales. The chb and nag clusters may constitute a strategy that allows L. paracasei to adapt to the gastrointestinal environment. KEY POINTS: • Lacticaseibacillus paracasei BL23 metabolizes N,N'-diacetylchitobiose • The chb and nag gene clusters are involved in N,N'-diacetylchitobiose metabolism • ChbR and NagR transcriptionally repressed the chb and nagAR clusters, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.